| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 3.8K |
| Renal clearance of quantum dots | Nature Biotechnology | 2007 | 3.3K |
| EGFR mutation and resistance of non-small-cell lung cancer to gefitinib | New England Journal of Medicine | 2005 | 3.3K |
| Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping | Nature Biotechnology | 2004 | 1.8K |
| Integrative clinical genomics of advanced prostate cancer | Cell | 2015 | 1.8K |
| New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway | Proceedings of the National Academy of Sciences of the United States of America | 1999 | 1.7K |
| Cancer of the ovary | New England Journal of Medicine | 2004 | 1.4K |
| The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress | Proceedings of the National Academy of Sciences of the United States of America | 2004 | 1.4K |
| Crizotinib in ROS1-rearranged non-small-cell lung cancer | New England Journal of Medicine | 2014 | 1.3K |
| Extrapulmonary manifestations of COVID-19 | Nature Medicine | 2020 | 1.3K |
| Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications | Cell Stress and Chaperones | 2005 | 1K |
| The PI3K pathway as drug target in human cancer | Journal of Clinical Oncology | 2010 | 992 |
| Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer | Journal of Clinical Oncology | 2015 | 859 |
| Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma | Journal of Clinical Oncology | 2004 | 847 |
| Combination cancer immunotherapy and new immunomodulatory targets | Nature Reviews Drug Discovery | 2015 | 806 |
| Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice | Proceedings of the National Academy of Sciences of the United States of America | 1997 | 776 |
| Protein tyrosine phosphatases in signal transduction | Current Opinion in Cell Biology | 1997 | 709 |
| Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer | Cell | 2009 | 691 |
| Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy | Nature | 2014 | 684 |
| Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma | New England Journal of Medicine | 2019 | 672 |
| Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway | New England Journal of Medicine | 2016 | 661 |
| Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released | Blood | 2008 | 648 |
| Design considerations for tumour-targeted nanoparticles | Nature Nanotechnology | 2010 | 633 |
| Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma | Journal of Clinical Oncology | 2005 | 624 |
| Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes | Nature | 1998 | 613 |
